Chemoprotection by transfer of resistance genes

Methods in Molecular Biology

Volumn 542, Issue , 2009, Pages 661-704

  Budak Alpdogan, Tulin ^a   Bertino, Joseph R ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

CD34+ cells; drug resistance gene; hematopoietic stem cells; murine models; myeloprotection; retroviral gene transfer; transduction

Indexed keywords

MURINAE;

CD34 ANTIGEN;

ANIMAL; ARTICLE; BONE MARROW CELL; CELL LINE; CELL PROTECTION; CLONOGENIC ASSAY; CYTOLOGY; DRUG RESISTANCE; FLOW CYTOMETRY; GENE TRANSFER; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HEMATOPOIETIC STEM CELL; HUMAN; METABOLISM; MOUSE; POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD34; BONE MARROW CELLS; CELL LINE; COLONY-FORMING UNITS ASSAY; CYTOPROTECTION; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; POLYMERASE CHAIN REACTION; TRANSDUCTION, GENETIC;

EID: 67650314978     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-561-9_34     Document Type: Review

References (276)

1. Bertino JR . "Turning the tables"-making normal marrow resistant to chemotherapy . J Natl Cancer Inst 1990 ; 82 (15) : 1234-5 .
2. Persons DA , Allay ER , Sawai N , et al . Successful treatment of murine beta-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells . Blood 2003 ; 102 (2) : 506-13 .
3. Havenga MJ , Werner AB , Valerio D , Van Es HH . Methotrexate selectable retroviral vectors for Gaucher disease . Gene Ther 1998 ; 5 (10) : 1379-88 .
4. Carella AM , Congiu AM , Gaozza E , et al . High-dose chemotherapy with autologous bone marrow transplantation in 50 adVanced resistant Hodgkin's disease patients: An Italian study group report . J Clin Oncol 1988 ; 6 (9) : 1411-6 .
5. Kollmannsberger C , Mayer F , Kuczyk M , Kanz L , Bokemeyer C . Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy . World J Urol 2001 ; 19 (2) : 120-5 .
6. Vuento MH , Salmi TA , Remes KJ , Grenman SE . Hematological toxicity of salvage treatment after high-dose chemotherapy and conventional chemotherapy of ovarian cancer . Anticancer Res 2002 ; 22 (2B) : 1151-5 .
7. Rapoport AP , Guo C , Badros A , et al . Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma . Bone Marrow Transplant 2004 ; 34 (10) : 883-90 .
8. Rapoport AP , Meisenberg B , Sarkodee- Adoo C , et al . Autotransplantation for adVanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/ GM-CSF or radiotherapy and consolidation chemotherapy . Bone Marrow Transplant 2002 ; 29 (4) : 303-12 .
9. Hesdorffer C , Ayello J , Ward M , et al . Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation . J Clin Oncol 1998 ; 16 (1) : 165-72 .
10. Eckert HG , Kuhlcke K , Schilz AJ , et al . Clinical scale production of an improved retroviral vector expressing the human multidrug resistance 1 gene (MDR1) . Bone Marrow Trans 2000 ; 25 (Suppl 2) : S114 - 7 .
11. Moscow JA , Huang H , Carter C , et al . Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy . Blood 1999 ; 94 (1) : 52-61 .
12. Sorrentino BP , Brandt SJ , Bodine D , et al . Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1 . Science 1992 ; 257 (5066) : 99-103 .
13. Schilz AJ , Schiedlmeier B , Kuhlcke K , et al . MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically releVant conditions . Mol Ther 2000 ; 2 (6) : 609-18 .
14. Sugimoto Y , Sato S , Tsukahara S , et al . Coexpression of a multidrug resistance gene (MDR1) and herpes simplex virus thymidine kinase gene in a bicistronic retroviral vector Ha-MDR-IRES-TK allows selective killing of MDR1-transduced human tumors transplanted in nude mice . Cancer Gene Ther 1997 ; 4 (1) : 51-8 .
15. Licht T , Goldenberg SK , Vieira WD , Gottesman MM , Pastan I . Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice . Gene Ther 2000 ; 7 (4) : 348-58 .
16. Cowan KH , Moscow JA , Huang H , et al . Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients . Clin Cancer Res 1999 ; 5 (7) : 1619-28 .
17. Abonour R , Williams DA , Einhorn L , et al . Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells . Nat Med 2000 ; 6 (6) : 652-8 .
18. Capiaux GM , Budak-Alpdogan T , Takebe N , et al . Retroviral transduction of a mutant dihydrofolate reductase-thymidylate synthase fusion gene into murine marrow ells confers resistance to both methotrexate and 5-Fluorouracil . Hum Gene Ther 2003 ; 14 (5) : 435-46 .
19. Sauerbrey A , McPherson JP , Zhao SC , Banerjee D , Bertino JR . Expression of a nov el double-mutant dihydrofolate reductasecytidine deaminase fusion gene confers resistance to both methotrexate and cytosine arabinoside . Hum Gene Ther 1999 ; 10 (15) : 2495-504 .
20. Mineishi S , Nakahara S , Takebe N , Banerjee D , Zhao SC , Bertino JR . Co-expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene . Gene Ther 1997 ; 4 (6) : 570-6 .
21. Takebe N , Zhao SC , Adhikari D , et al . Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene . Mol Ther 2001 ; 3 (1) : 88-96 .
22. Beausejour CM , Le NL , Letourneau S , Cournoyer D , Momparler RL . Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate . Hum Gene Ther 1998 ; 9 (17) : 2537-44 .
23. Wang J , Chen Z , Xia X , Lu D , Xue J , Ruan C . A bicistronic retroviral vector to introduce drug resistance genes into human umbilical cord blood CD 34+ cells to improve combination chemotherapy tolerance . Chin Med J (Engl) 2001 ; 114 (1) : 25-9 .
24. Suzuki M , Sugimoto Y , Tsukahara S , Okochi E , Gottesman MM , Tsuruo T . Retroviral coexpression of two different types of drug resistance genes to protect normal cells from combination chemotherapy . Clin Cancer Res 1997 ; 3 (6) : 947-54 .
25. Suzuki M , Sugimoto Y , Tsuruo T . Efficient protection of cells from the genotoxicity of nitrosoureas by the retrovirus-mediated transfer of human O6-methylguanine-DNA methyltransferase using bicistronic vectors with human multidrug resistance gene 1 . Mutat Res 1998 ; 401 (1-2) : 133-41 .
26. Belzile JP , Karatzas A , Shiu HY , Letourneau S , Palerme JS , Cournoyer D . Increased resistance to nitrogen mustards and antifolates following in vitro selection of murine fibroblasts and primary hematopoietic cells transduced with a bicistronic retroviral vector expressing the rat glutathione S-transferase A3 and a mutant dihydrofolate reductase . Cancer Gene Ther 2003 ; 10 (8) : 637-46 .
27. Rappa G , Lorico A , Hildinger M , Fodstad O , Baum C . Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agents . Hum Gene Ther 2001 ; 12 (14) : 1785-96 .
28. Richard E , Geronimi F , Lalanne M , et al . A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell lines . J Gene Med 2003 ; 5 (9) : 737-47 .
29. Amendola M , Venneri MA , Biffi A , Vigna E , Naldini L . Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters . Nat Biotechnol 2005 ; 23 (1) : 108-16 .
30. Fux C , Fussenegger M . Bidirectional expression units enable streptogramin-adjustable gene expression in mammalian cells . Biotechnol Bioeng 2003 ; 83 (5) : 618-25 .
31. Ray S , Paulmurugan R , Hildebrandt I , et al . Novel bidirectional vector strategy for amplification of therapeutic and reporter gene expression . Hum Gene Ther 2004 ; 15 (7) : 681-90 .
32. Weissinger F , Reimer P , Waessa T , et al . Gene transfer in purified human hematopoietic peripheral-blood stem cells by means of electroporation without prestimulation . J Lab Clin Med 2003 ; 141 (2) : 138-49 .
33. Wu MH , Liebowitz DN , Smith SL , Williams SF , Dolan ME . Efficient expression of foreign genes in human CD34(+) hematopoietic precursor cells using electroporation . Gene Ther 2001 ; 8 (5) : 384-90 .
34. Wu MH , Smith SL , Danet GH , et al . Optimization of culture conditions to enhance transfection of human CD34+ cells by electroporation . Bone Marrow Trans 2001 ; 27 (11) : 1201-9 .
35. Wu MH , Smith SL , Dolan ME . High efficiency electroporation of human umbilical cord blood CD34+ hematopoietic precursor cells . Stem Cells 2001 ; 19 (6) : 492-9 .
36. Geurts AM , Yang Y , Clark KJ , et al . Gene transfer into genomes of human cells by the sleeping beauty transposon system . Mol Ther 2003 ; 8 (1) : 108-17 .
37. Izsvak Z , Ivics Z , Plasterk RH . Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates . J Mol Biol 2000 ; 302 (1) : 93-102 .
38. Yant SR , Meuse L , Chiu W , Ivics Z , Izsvak Z , Kay MA . Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system . Nat Genet 2000 ; 25 (1) : 35-41 .
39. Mikkelsen JG , Yant SR , Meuse L , Huang Z , Xu H , Kay MA . Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo . Mol Ther 2003 ; 8 (4) : 654-65 .
40. Liu G , Geurts AM , Yae K , et al . Target-site preferences of Sleeping Beauty transposons . J Mol Biol 2005 ; 346 (1) : 161-73 .
41. Huang X , Wilber AC , Bao L , et al . Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system . Blood 2006 ; 107 (2) : 483-91 .
42. Fernando S , Fletcher BS . Sleeping beauty transposon-mediated nonviral gene therapy .BioDrugs 2006 ; 20 (4) : 219-29 .
43. Hollis RP , Nightingale SJ , Wang X , et al . Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposon . Exp Hematol 2006 ; 34 (10) : 1333-43 .
44. Wilson MH , Coates CJ , George AL , Jr . PiggyBac Transposon-mediated Gene Transfer in Human Cells . Mol Ther 2007 ; 15 (1) : 139-45
45. Yant SR , Huang Y , Akache B , Kay MA . Sitedirected transposon integration in human cells . Nucleic Acids Res 2007 ; 35 (7) : E50 .
46. Wright DA , Thibodeau-Beganny S , Sander JD , et al . Standardized reagents and protocols for engineering zinc finger nucleases by modular assembly . Nat Protoc 2006 ; 1 (3) : 1637-52 .
47. Moehle EA , Rock JM , Lee YL , et al . Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases . Proc Natl Acad Sci U S 2007 ; 104 (9) : 3055-60 .
48. Hacein-Bey-Abina S , Von Kalle C , Schmidt M , et al . LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 . Science 2003 ; 302 (5644) : 415-9 .
49. Hacein-Bey-Abina S , von Kalle C , Schmidt M , et al . A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency . N Engl J Med 2003 ; 348 (3) : 255-6 .
50. Couzin J , Kaiser J . Gene therapy. As Gelsinger case ends, gene therapy suffers another blow . Science 2005 ; 307 (5712) : 1028 .
51. Baum C . What are the consequences of the fourth case? Mol Ther 2007 ; 15 (8) : 1401-2 .
52. Lewinski MK , Bushman FD . Retroviral DNA integration-mechanism and consequences . Adv Genet 2005 ; 55 : 147-81 .
53. Lewinski MK , Yamashita M , Emerman M , et al . Retroviral DNA integration: Viral and cellular determinants of target-site selection . PLoS Pathog 2006 ; 2 (6) : E60 .
54. Kustikova O , Fehse B , Modlich U , et al . Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking . Science 2005 ; 308 (5725) : 1171-4 .
55. Montini E , Cesana D , Schmidt M , et al . Hematopoietic stem cell gene transfer in tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration . Nat Biotechnol 2006 ; 24 (6) : 687-96 .
56. Deichmann A , Hacein-Bey-Abina S , Schmidt M , et al . Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy . J Clin Invest 2007 ; 117 (8) : 2225-32 .
57. Cattoglio C , Facchini G , Sartori D , et al . Hot spots of retroviral integration in human CD34+ hematopoietic cells . Blood 2007 ; 110 (6) : 1770-8 .
58. Beard BC , Dickerson D , Beebe K , et al . Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells . Mol Ther 2007 ; 15 (7) : 1356-65 .
59. Bushman FD . Retroviral integration and human gene therapy . J Clin Invest 2007 ; 117 (8) : 2083-6 .
60. Trobridge GD , Miller DG , Jacobs MA , et al . Foamy virus vector integration sites in normal human cells . Proc Natl Acad Sci U S 2006 ; 103 (5) : 1498-503 .
61. Baum C , Kustikova O , Modlich U , Li Z , Fehse B . Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors . Hum Gene Ther 2006 ; 17 (3) : 253-63 .
62. Modlich U , Kustikova OS , Schmidt M , et al . Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis . Blood 2005 ; 105 (11) : 4235-46 .
63. Dave UP , Jenkins NA , Copeland NG . Gene therapy insertional mutagenesis insights . Science 2004 ; 303 (5656) : 333 .
64. Kustikova OS , Geiger H , Li Z , et al . Retroviral vector insertion sites associated with dominant hematopoietic clones mark "stemness" pathways . Blood 2007 ; 109 (5) : 1897 - 907 .
65. Hargrove PW , Kepes S , Hanawa H , et al . Globin lentiviral vector insertions can perturb the expression of endogenous genes in beta-thalassemic hematopoietic cells . Mol Ther 2008 ; 16 (3) : 525-33 .
66. Seggewiss R , Pittaluga S , Adler RL , et al . Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque . Blood 2006 ; 107 (10) : 3865-7 .
67. Baum C . Insertional mutagenesis in gene therapy and stem cell biology . Curr Opin Hematol 2007 ; 14 (4) : 337-42 .
68. Siapati EK , Bigger BW , Kashofer K , Themis M , Thrasher AJ , Bonnet D . Murine leukemia following irradiation conditioning for transplantation of lentivirally-modified hematopoietic stem cells . Eur J Haematol 2007 ; 78 (4) : 303-13 .
69. Li Z , Dullmann J , Schiedlmeier B , et al . Murine leukemia induced by retroviral gene marking . Science 2002 ; 296 (5567) : 497 .
70. Wu X , Li Y , Crise B , Burgess SM . Transcription start regions in the human genome are favored targets for MLV integration . Science 2003 ; 300 (5626) : 1749-51 .
71. Mitchell RS , Beitzel BF , Schroder AR , et al . Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences . PLoS Biol 2004 ; 2 (8) : E234 .
72. Schmidt M , Hoffmann G , Wissler M , et al . Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples . Hum Gene Ther 2001 ; 12 (7) : 743-9 .
73. Hematti P , Hong BK , Ferguson C , et al . Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells . PLoS Biol 2004 ; 2 (12) : E423 .
74. Will E , Bailey J , Schuesler T , et al . Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials . Mol Ther 2007 ; 15 (4) : 782-91 .
75. Schmidt M , Schwarzwaelder K , Bartholomae C , et al . High-resolution insertion-site analysis by linear amplification-mediated PCR (LAMPCR) . Nat Methods 2007 ; 4 (12) : 1051-7 .
76. Ott MG , Schmidt M , Schwarzwaelder K , et al . Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 . Nat Med 2006 ; 12 (4) : 401-9 .
77. Schmidt M , Carbonaro DA , Speckmann C , et al . Clonality analysis after retroviralmediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates . Nat Med 2003 ; 9 (4) : 463-8 .
78. Kraunus J , Schaumann DH , Meyer J , et al . Self-inactivating retroviral vectors with improved RNA processing . Gene Ther 2004 ; 11 (21) : 1568-78 .
79. Modlich U , Bohne J , Schmidt M , et al . Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity . Blood 2006 ; 108 (8) : 2545-53 .
80. Schambach A , Mueller D , Galla M , et al . Overcoming promoter competition in packaging cells improves production of selfinactivating retroviral vectors . Gene Ther 2006 ; 13 (21) : 1524-33 .
81. Schambach A , Bohne J , Chandra S , et al . Equal potency of gammaretroviral and lenti viral SIN vectors for expression of O6-methylguanine- DNA methyltransferase in hematopoietic cells . Mol Ther 2006 ; 13 (2) : 391-400 .
82. Schambach A , Galla M , Maetzig T , Loew R , Baum C . Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors . Mol Ther 2007 ; 15 (6) : 1167-73 .
83. Thornhill SI , Schambach A , Howe SJ , et al . Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency . Mol Ther 2008 ; 16 (3) : 590-8 .
84. Zychlinski D, Schambach A, Modlich U, et al. Physiological Promoters Reduce the Genotoxic Risk of Integrating Gene Vectors. Mol Ther 2008.
85. Ryu BY , EVans-Galea MV , Gray JT , Bodine DM , Persons DA , Nienhuis AW . An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation . Blood 2008 ; 111 (4) : 1866-75 .
86. Leurs C , Jansen M , Pollok KE , et al . Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells . Hum Gene Ther 2003 ; 14 (6) : 509-19 .
87. Josephson NC , Vassilopoulos G , Trobridge GD , et al . Transduction of human NOD/ SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors . Proc Natl Acad Sci U S A 2002 ; 99 (12) : 8295-300 .
88. Gatlin J , Padgett A , Melkus MW , Kelly PF , Garcia JV . Long-term engraftment of nonobese diabetic/severe combined immunodeficient mice with human CD34+ cells transduced by a self-inactivating human immunodeficiency virus type 1 vector . Hum Gene Ther 2001 ; 12 (9) : 1079-89 .
89. Haas DL , Case SS , Crooks GM , Kohn DB . Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors . Mol Ther 2000 ; 2 (1) : 71-80 .
90. Karlsson S , Ooka A , Woods NB . Development of gene therapy for blood disorders by gene transfer into haematopoietic stem cells . Haemophilia 2002 ; 8 (3) : 255-60 .
91. Kimchi-Sarfaty C , Arora M , Sandalon Z , Oppenheim A , Gottesman MM . High cloning capacity of in vitro packaged SV40 vectors with no SV40 virus sequences . Hum Gene Ther 2003 ; 14 (2) : 167-77 .
92. Kimchi-Sarfaty C , Gottesman MM . SV40 pseudovirions as highly efficient vectors for gene transfer and their potential application in cancer therapy . Curr Pharm Biotechnol 2004 ; 5 (5) : 451-8 .
93. Kimchi-Sarfaty C , Alexander NS , Brittain S , Ali S , Gottesman MM . Transduction of multiple cell types using improved conditions for gene delivery and expression of SV40 pseudovirions packaged in vitro . Biotechniques 2004 ; 37 (2) : 270-5 .
94. Vassilopoulos G , Trobridge G , Josephson NC , Russell DW . Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors . Blood 2001 ; 98 (3) : 604-9 .
95. Russell DW , Miller AD . Foamy virus vectors . J Virol 1996 ; 70 (1) : 217-22 .
96. Trobridge G , Vassilopoulos G , Josephson N , Russell DW . Gene transfer with foamy virus vectors . Methods Enzymol 2002 ; 346 : 628-48 .
97. Lombardo A , Genovese P , Beausejour CM , et al . Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery . Nat Biotechnol 2007 ; 25 (11) : 1298-306 .
98. Brown BD , Gentner B , Cantore A , et al . Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state . Nat Biotechnol 2007 ; 25 (12) : 1457-67 .
99. Brown BD , Cantore A , Annoni A , et al . A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice . Blood 2007 ; 110 (13) : 4144-52 .
100. Riviere I , Sadelain , M.W.J. Methods for the construction of etroviral vectors and the generation of high titer producers . In: Robbins P , ed. Methods in Molecular Medicine . Totowa , Humana Press , 1997 , pp. 59 - 78 .
101. Berger C , Flowers ME , Warren EH , Riddell SR . Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TKmodified donor T cells after allogeneic hematopoietic cell transplantation . Blood 2006 ; 107 (6) : 2294-302 .
102. Chalmers D , Ferrand C , Apperley JF , et al . Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene . Mol Ther 2001 ; 4 (2) : 146-8 .
103. Garin MI , Garrett E , Tiberghien P , et al . Molecular mechanism for ganciclovir resistancein human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene . Blood 2001 ; 97 (1) : 122-9 .
104. Sato T , Neschadim A , Konrad M , Fowler DH , Lavie A , Medin JA . Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy . Mol Ther 2007 ; 15 (5) : 962-70 .
105. Carbonaro DA , Jin X , Petersen D , et al . In vivo transduction by intravenous injection of a lentiviral vector expressing human ADA into neonatal ADA gene knockout mice: A novel form of enzyme replacement therapy for ADA deficiency . Mol Ther 2006 ; 13 (6) : 1110-20 .
106. Alfa RW , Blesch A . Murine and HIV-based retroviral vectors for in vitro and in vivo gene transfer . Methods Mol Med 2006 ; 129 : 241-54 .
107. Worsham DN , Schuesler T , von Kalle C , Pan D . In vivo gene transfer into adult stem cells in unconditioned mice by in situ delivery of a lentiviral vector . Mol Ther 2006 ; 14 (4) : 514-24 .
108. Aires da Silva F , Costa MJ , Corte-Real S , Goncalves J . Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies . Hum Gene Ther 2005 ; 16 (2) : 223-34 .
109. Roe T , Reynolds TC , Yu G , Brown PO . Integration of murine leukemia virus DNA depends on mitosis . Embo J 1993 ; 12 (5) : 2099-108 .
110. Orlic D , Girard LJ , Anderson SM , et al . Identification of human and mouse hematopoietic stem cell populations expressing high levels of mRNA encoding retrovirus receptors . Blood 1998 ; 91 (9) : 3247-54 .
111. Orlic D , Girard LJ , Jordan CT , Anderson SM , Cline AP , Bodine DM . The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction . Proc Natl Acad Sci U S A 1996 ; 93 (20) : 11097-102 .
112. Orlic D , Girard LJ , Anderson SM , Barrette S , Broxmeyer HE , Bodine DM . Amphotropic retrovirus transduction of hematopoietic stem cells . Ann N Y Acad Sci 1999 ; 872 : 115 - 23 ; discussion 23-4.
113. Sabatino DE , Do BQ , Pyle LC , et al . Amphotropic or gibbon ape leukemia virus retrovirus binding and transduction correlates with the level of receptor mRNA in human hematopoietic cell lines . Blood Cells Mol Dis 1997 ; 23 (3) : 422-33 .
114. Barrette S , Douglas J , Orlic D , et al . Superior transduction of mouse hematopoietic stem cells with 10A1 and VSV-G pseudotyped retrovirus vectors . Mol Ther 2000 ; 1 (4) : 330-8 .
115. Zielske SP , Gerson SL . Cytokines, including stem cell factor alone, enhance lentiviral transduction in nondividing human LTCIC and NOD/SCID repopulating cells . Mol Ther 2003 ; 7 (3) : 325-33 .
116. Mazurier F , Gan OI , McKenzie JL , Doedens M , Dick JE . Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment . Blood 2004 ; 103 (2) : 545-52 .
117. Tisdale JF , Hanazono Y , Sellers SE , et al . Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability . Blood 1998 ; 92 (4) : 1131-41 .
118. Dorrell C , Gan OI , Pereira DS , Hawley RG , Dick JE . Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: Dissociation of SRC phenotype and function . Blood 2000 ; 95 (1) : 102-10 .
119. Gothot A , Van der Loo JC , Clapp DW , Srour EF . Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/ severe combined immune-deficient mice . Blood 1998 ; 92 (8) : 2641-9 .
120. Zielske SP , Gerson SL . Lentiviral transduction of P140K MGMT into human CD34(+) hematopoietic progenitors at low multiplicity of infection confers significant resistance to BG/BCNU and allows selection in vitro . Mol Ther 2002 ; 5 (4) : 381-7 .
121. Galimi F , Noll M , Kanazawa Y , et al . Gene therapy of Fanconi anemia: Preclinical efficacy using lentiviral vectors . Blood 2002 ; 100 (8) : 2732-6 .
122. Sandrin V , Boson B , Salmon P , et al . Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates . Blood 2002 ; 100 (3) : 823-32 .
123. Trobridge G , Russell DW . Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors . J Virol 2004 ; 78 (5) : 2327-35 .
124. Mostoslavsky G , Kotton DN , Fabian AJ , Gray JT , Lee JS , Mulligan RC . Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation . Mol Ther 2005 ; 11 (6) : 932-40 .
125. Budak-Alpdogan T , Przybylowski M , Gonen M , Sadelain M , Bertino J , Riviere I . Functional assessment of the engraftment potential of gammaretrovirus-modified CD34+ cells, using a short serum-free transduction protocol . Hum Gene Ther 2006 ; 17 (7) : 780-94 .
126. Deola S , Scaramuzza S , Birolo RS , et al . Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-Hu mice . Hum Gene Ther 2004 ; 15 (3) : 305-11 .
127. Moritz T , Dutt P , Xiao X , et al . Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: Evidence of direct viral binding to chymotryptic carboxy-terminal fragments . Blood 1996 ; 88 (3) : 855-62 .
128. Hanenberg H , Hashino K , Konishi H , Hock RA , Kato I , Williams DA . Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells . Hum Gene Ther 1997 ; 8 (18) : 2193-206 .
129. Moritz T , Patel VP , Williams DA . Bone marrow extracellular matrix molecules improve with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies . Hum Gene Ther 2005 ; 16 (2) : 223-34
130. Roe T , Reynolds TC , Yu G , Brown PO . Integration of murine leukemia virus DNA depends on mitosis . Embo J 1993 ; 12 (5) : 2099-108
131. Orlic D , Girard LJ , Anderson SM , et al . Identification of human and mouse hematopoietic stem cell populations expressing high levels of mRNA encoding retrovirus receptors . Blood 1998 ; 91 (9) : 3247-54 .
132. Orlic D , Girard LJ , Jordan CT , Anderson SM , Cline AP , Bodine DM . The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction . Proc Natl Acad Sci U S A 1996 ; 93 (20) : 11097-102 .
133. Orlic D , Girard LJ , Anderson SM , Barrette S , Broxmeyer HE , Bodine DM . Amphotropic retrovirus transduction of hematopoietic stem cells . Ann N Y Acad Sci 1999 ; 872 : 115 - 23 ; discussion 23-4.
134. Sabatino DE , Do BQ , Pyle LC , et al . Amphotropic or gibbon ape leukemia virus retrovirus binding and transduction correlates with the level of receptor mRNA in human hematopoietic cell lines . Blood Cells Mol Dis 1997 ; 23 (3) : 422-33 .
135. Barrette S , Douglas J , Orlic D , et al . Superior transduction of mouse hematopoietic stem cells with 10A1 and VSV-G pseudotyped retrovirus vectors . Mol Ther 2000 ; 1 (4) : 330-8 .
136. Zielske SP , Gerson SL . Cytokines, including stem cell factor alone, enhance lentiviral transduction in nondividing human LTCIC and NOD/SCID repopulating cells . Mol Ther 2003 ; 7 (3) : 325-33 .
137. Mazurier F , Gan OI , McKenzie JL , Doedens M , Dick JE . Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment . Blood 2004 ; 103 (2) : 545-52 .
138. Tisdale JF , Hanazono Y , Sellers SE , et al . Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability . Blood 1998 ; 92 (4) : 1131-41 .
139. Dorrell C , Gan OI , Pereira DS , Hawley RG , Dick JE . Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: Dissociation of SRC phenotype and function . Blood 2000 ; 95 (1) : 102-10 .
140. Gothot A , Van der Loo JC , Clapp DW , Srour EF . Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/ severe combined immune-deficient mice . Blood 1998 ; 92 (8) : 2641-9 .
141. Zielske SP , Gerson SL . Lentiviral transduction of P140K MGMT into human CD34(+) hematopoietic progenitors at low multiplicity of infection confers significant resistance to BG/BCNU and allows selection in vitro . Mol Ther 2002 ; 5 (4) : 381-7 .
142. Galimi F , Noll M , Kanazawa Y , et al . Gene therapy of Fanconi anemia: Preclinical efficacy using lentiviral vectors . Blood 2002 ; 100 (8) : 2732-6 .
143. Sandrin V , Boson B , Salmon P , et al . Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates . Blood 2002 ; 100 (3) : 823-32 .
144. Trobridge G , Russell DW . Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors . J Virol 2004 ; 78 (5) : 2327-35 .
145. Mostoslavsky G , Kotton DN , Fabian AJ , Gray JT , Lee JS , Mulligan RC . Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation . Mol Ther 2005 ; 11 (6) : 932-40 .
146. Budak-Alpdogan T , Przybylowski M , Gonen M , Sadelain M , Bertino J , Riviere I . Functional assessment of the engraftment potential of gammaretrovirus-modified CD34+ cells, using a short serum-free transduction protocol . Hum Gene Ther 2006 ; 17 (7) : 780-94 .
147. Deola S , Scaramuzza S , Birolo RS , et al . Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-Hu mice . Hum Gene Ther 2004 ; 15 (3) : 305-11 .
148. Moritz T , Dutt P , Xiao X , et al . Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: Evidence of direct viral binding to chymotryptic carboxy-terminal fragments . Blood 1996 ; 88 (3) : 855-62 .
149. Hanenberg H , Hashino K , Konishi H , Hock RA , Kato I , Williams DA . Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells . Hum Gene Ther 1997 ; 8 (18) : 2193-206
150. Moritz T , Patel VP , Williams DA . Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors . J Clin Invest 1994 ; 93 (4) : 1451-7 .
151. Pollok KE , Williams DA . Facilitation of retrovirus- mediated gene transfer into hematopoietic stem and progenitor cells and peripheral blood T-lymphocytes utilizing recombinant fibronectin fragments . Curr Opin Mol Ther 1999 ; 1 (5) : 595-604 .
152. Persons DA , Mehaffey MG , Kaleko M , Nienhuis AW , Vanin EF . An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene . Blood Cells Mol Dis 1998 ; 24 (2) : 167-82 .
153. Kwon YJ , Peng CA . Transduction rate constant as more reliable index quantifying efficiency of retroviral gene delivery . Biotechnol Bioeng 2002 ; 77 (6) : 668-77 .
154. Kwon YJ , Hung G , Anderson WF , Peng CA , Yu H . Determination of infectious retro virus concentration from colony-forming assay with quantitative analysis . J Virol 2003 ; 77 (10) : 5712-20 .
155. Davis HE , Morgan JR , Yarmush ML . Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes . Biophys Chem 2002 ; 97 (2-3) : 159-72 .
156. Davis HE , Rosinski M , Morgan JR , Yarmush ML . Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation . Biophys J 2004 ; 86 (2) : 1234-42 .
157. Bahnson AB , Dunigan JT , Baysal BE , et al . Centrifugal enhancement of retroviral mediated gene transfer . J Virol Methods 1995 ; 54 (2-3) : 131-43 .
158. Kuhlcke K , Fehse B , Schilz A , et al . Highly efficient retroviral gene transfer based on centrifugation-mediated vector preloading of tissue culture vessels . Mol Ther 2002 ; 5 (4) : 473-8 .
159. Takiyama N , Mohney T , Swaney W , et al . Comparison of methods for retroviral mediated transfer of glucocerebrosidase gene to CD34+ hematopoietic progenitor cells . Eur J Haematol 1998 ; 61 (1) : 1-6 .
160. Sanyal A , Schuening FG . Increased gene transfer into human cord blood cells by centrifugation-enhanced transduction in fibronectin fragment-coated tubes . Hum Gene Ther 1999 ; 10 (17) : 2859-68 .
161. Movassagh M , Desmyter C , Baillou C , et al . High-level gene transfer to cord blood progenitors using gibbon ape leukemia virus pseudotype retroviral vectors and an improved clinically applicable protocol . Hum Gene Ther 1998 ; 9 (2) : 225-34 .
162. Campain JA , Terrell KL , Tomczak JA , Shpall EJ , Hami LS , Harrison GS . Comparison of retroviral-mediated gene transfer into cultured human CD34+ hematopoietic progenitor cells derived from peripheral blood, bone marrow, and fetal umbilical cord blood . Biol Blood Marrow Transplant 1997 ; 3 (5) : 273-81 .
163. Relander T , Brun A , Hawley RG , Karlsson S , Richter J . Retroviral transduction of human CD34+ cells on fibronectin fragment CH-296 is inhibited by high concentrations of vector containing medium . J Gene Med 2001 ; 3 (3) : 207-18 .
164. Murray L , Luens K , Tushinski R , et al . Optimization of retroviral gene transduction of mobilized primitive hematopoietic progenitors by using thrombopoietin, Flt3, and Kit ligands and RetroNectin culture . Hum Gene Ther 1999 ; 10 (11) : 1743-52 .
165. Chono H , Yoshioka H , Ueno M , Kato I . Removal of inhibitory substances with recombinant fibronectin-CH-296 plates enhances the retroviral transduction efficiency of CD34(+)CD38(-) bone marrow cells . J Biochem (Tokyo) 2001 ; 130 (3) : 331-4 .
166. Kustikova OS , Wahlers A , Kuhlcke K , et al . Dose finding with retroviral vectors: Correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population . Blood 2003 ; 102 (12) : 3934-7 .
167. Murray LJ , Young JC , Osborne LJ , Luens KM , Scollay R , Hill BL . Thrombopoietin, flt3, and kit ligands together suppress apoptosis of human mobilized CD34+ cells and recruit primitive CD34+ Thy- 1+ cells into rapid division . Exp Hematol 1999 ; 27 (6) : 1019-28 .
168. Herrera C , Sanchez J , Torres A , Bellido C , Rueda A , Alvarez MA . Early-acting cytokine-driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post-mitotic offspring with preserved engraftment ability in non-obese diabetic/ severe combined immunodeficient mice . Br J Haematol 2001 ; 114 (4) : 920-30 .
169. Trarbach T , Greifenberg S , Bardenheuer W , et al . Optimized retroviral transduction protocol for human progenitor cells utilizing fibronectin fragments . Cytotherapy 2000 ; 2 (6) : 429-38 .
170. Hennemann B , Conneally E , Pawliuk R , et al . Optimization of retroviral-mediated gene transfer to human NOD/SCID mouse repopulating cord blood cells through a systematic analysis of protocol variables . Exp Hematol 1999 ; 27 (5) : 817-25 .
171. Van der Loo JC , Liu BL , Goldman AI , Buckley SM , Chrudimsky KS . Optimization of gene transfer into primitive human hematopoietic cells of granulocyte-colony stimulating factor-mobilized peripheral blood using low-dose cytokines and comparison of a gibbon ape leukemia virus versus an RD114-pseudotyped retroviral vector . Hum Gene Ther 2002 ; 13 (11) : 1317-30 .
172. Relander T , Karlsson S , Richter J . Oncoretroviral gene transfer to NOD/SCID repopulating cells using three different viral envelopes . J Gene Med 2002 ; 4 (2) : 122-32 .
173. Ott MG , Merget-Millitzer H , Ottmann OG , et al . Mobilization and transduction of CD34(+) peripheral blood stem cells in patients with X-linked chronic granulomatous disease . J Hematother Stem Cell Res 2002 ; 11 (4) : 683-94 .
174. Demaison C , Brouns G , Blundell MP , et al . A defined window for efficient gene marking of severe combined immunodeficientrepopulating cells using a gibbon ape leu kemia virus-pseudotyped retroviral vector . Hum Gene Ther 2000 ; 11 (1) : 91-100 .
175. Gaspar HB , Parsley KL , Howe S , et al . Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector . Lancet 2004 ; 364 (9452) : 2181-7 .
176. Zhang XB , Beard BC , Trobridge GD , et al . High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4- expressing retroviral vector . J Clin Invest 2008 ; 118 (4) : 1502-10 .
177. Neff T, Beard BC, Peterson LJ, Anandakumar P, Thompson J, Kiem HP. Polyclonal chemoprotection against temozolomide in a large animal model of drug resistance gene therapy. Blood 2004.
178. Morris JC , Conerly M , Thomasson B , Storek J , Riddell SR , Kiem HP . Induction of cytotoxic T-lymphocyte responses to enhanced green and yellow fluorescent proteins after myeloablative conditioning . Blood 2004 ; 103 (2) : 492-9 .
179. Thomasson B , Peterson L , Thompson J , Goerner M , Kiem HP . Direct comparison of steady-state marrow, primed marrow, and mobilized peripheral blood for transduction of hematopoietic stem cells in dogs . Hum Gene Ther 2003 ; 14 (17) : 1683-6 .
180. Kiem HP , Andrews RG , Morris J , et al . Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor . Blood 1998 ; 92 (6) : 1878-86 .
181. Kiem HP , Heyward S , Winkler A , et al . Gene transfer into marrow repopulating cells: Comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons . Blood 1997 ; 90 (11) : 4638-45 .
182. Beard BC , Keyser KA , Trobridge GD , et al . Unique integration profiles in a canine model of long-term repopulating cells transduced with gammaretrovirus, lentivirus, or foamy virus . Hum Gene Ther 2007 ; 18 (5) : 423-34 .
183. Stead RB , Kwok WW , Storb R , Miller AD . Canine model for gene therapy: Inefficient gene expression in dogs reconstituted with autologous marrow infected with retroviral vectors . Blood 1988 ; 71 (3) : 742-7 .
184. Kiem HP , Sellers S , Thomasson B , et al . Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia . Mol Ther 2004 ; 9 (3) : 389-95 .
185. Wu T , Kim HJ , Sellers SE , et al . Prolonged high-level detection of retrovirally marked hematopoietic cells in nonhuman primates after transduction of CD34+ progenitors using clinically feasible methods . Mol Ther 2000 ; 1 (3) : 285-93 .
186. Hanazono Y , Nagashima T , Takatoku M , et al . In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate model . Gene Ther 2002 ; 9 (16) : 1055-64 .
187. Bodine DM , McDonagh KT , Seidel NE , Nienhuis AW . Survival and retrovirus infection of murine hematopoietic stem cells in vitro: Effects of 5-FU and method of infection . Exp Hematol 1991 ; 19 (3) : 206-12 .
188. Sato T , Laver JH , Ogawa M . Reversible expression of CD34 by murine hematopoietic stem cells . Blood 1999 ; 94 (8) : 2548-54 .
189. James RI , Warlick CA , Diers MD , Gunther R , McIvor RS . Mild preconditioning and low-level engraftment confer methotrexate resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity . Blood 2000 ; 96 (4) : 1334-41 .
190. Kramer BA , Lemckert FA , Alexander IE , Gunning PW , McCowage GB . Characterisation of a P140K mutant O6-methylguanine- DNA-methyltransferase (MGMT)-expressing transgenic mouse line with drug-selectable bone marrow . J Gene Med 2006 ; 8 (9) : 1071-85 .
191. Wyss BK , Meyers JL , Sinn AL , Cai S , Pollok KE repopulation strategy to quantitate engraftment of ex vivo manipulated murine marrow cells in submyeloablated hosts . Exp Hematol 2008 ; 36 (4) : 513-21 .
192. Flasshove M , Banerjee D , Mineishi S , Li MX , Bertino JR , Moore MA . Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer . Blood 1995 ; 85 (2) : 566-74 .
193. Piacibello W , Bruno S , Sanavio F , et al . Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient . Blood 2002 ; 100 (13) : 4391-400 .
194. Muhlebach MD , Schmitt I , Steidl S , et al . Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes . J Mol Med 2003 ; 81 (12) : 801-10 .
195. Einerhand MP , Bakx TA , Kukler A , Valerio D . Factors affecting the transduction of pluripotent hematopoietic stem cells: long-term expression of a human adenosine deaminase gene in mice . Blood 1993 ; 81 (1) : 254-63 .
196. Demarquoy J , Herman GE , Lorenzo I , Trentin J , Beaudet AL , O'Brien WE . Longterm expression of human argininosuccinate synthetase in mice following bone marrow transplantation with retrovirus-transduced hematopoietic stem cells . Hum Gene Ther 1992 ; 3 (1) : 3-10 .
197. Swift S, Lorens J, Achacoso P, Nolan GP. Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr Protoc Immunol 2001;Chapter 10:Unit 10 7C.
198. Rattmann I , Kleff V , Feldmann A , et al . Reliable generation of stable high titer producer cell lines for gene therapy . Intervirology 2007 ; 50 (3) : 197-203 .
199. Przybylowski M, Hakakha A, Stefanski J, Hodges J, Sadelain M, Riviere I. Production scale-up and validation of packaging cell clearance of clinical-grade retroviral vector stocks produced in Cell Factories. Gene Ther 2005.
200. Zaiss AK , Muruve DA . Immunity to adenoassociated virus vectors in animals and humans: A continued challenge . Gene Ther 2008 ; 15 (11) : 808-16 .
201. Follenzi A , Santambrogio L , Annoni A . Immune responses to lentiviral vectors . Curr Gene Ther 2007 ; 7 (5) : 306-15 .
202. Tuschong L , Soenen SL , Blaese RM , Candotti F , Muul LM . Immune response to fetal calf serum by two adenosine deaminasedeficient patients after T cell gene therapy . Hum Gene Ther 2002 ; 13 (13) : 1605-10 .
203. Kustikova OS , Baum C , Fehse B . Retroviral integration site analysis in hematopoietic stem cells . Methods Mol Biol 2008 ; 430 : 255-67 .
204. Hirose M , Hosoi E , Hamano S , Jalili A . Multidrug resistance in hematological malignancy . J Med Invest 2003 ; 50 (3-4) : 126-35 .
205. Leonard GD , Fojo T , Bates SE . The role of ABC transporters in clinical practice . Oncologist 2003 ; 8 (5) : 411-24 .
206. Robert J . Multidrug resistance in oncology: Diagnostic and therapeutic approaches . Eur J Clin Invest 1999 ; 29 (6) : 536-45 .
207. Budak-Alpdogan T , Alpdogan O , Banerjee D , Wang E , Moore MA , Bertino JR . Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene . Mol Ther 2004 ; 10 (3) : 574-84 .
208. Zhao SC , Banerjee D , Mineishi S , Bertino JR . Post-transplant methotrexate administration leads to improved curability of mice bearing a mammary tumor transplanted with marrow transduced with a mutant human dihydrofolate reductase cDNA . Hum Gene Ther 1997 ; 8 (8) : 903-9 .
209. Yahata T , Ando K , Miyatake H , et al . Competitive repopulation assay of two gene-marked cord blood units in NOD/ SCID/gammac(null) mice . Mol Ther 2004 ; 10 (5) : 882-91 .
210. Ito M , Kobayashi K , Nakahata T . NOD/Shiscid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models . Curr Top Microbiol Immunol 2008 ; 324 : 53-76 .
211. Ito M , Hiramatsu H , Kobayashi K , et al . NOD/SCID/gamma(null) mouse: An excellent recipient mouse model for engraft - ment of human cells . Blood 2002 ; 100 (9) : 3175-82 .
212. Knipper R , Kuehlcke K , Schiedlmeier B , et al . Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells . Gene Ther 2001 ; 8 (3) : 239-46 .
213. Licht T , Aran JM , Goldenberg SK , Vieira WD , Gottesman MM , Pastan I . Retroviral transfer of human MDR1 gene to hematopoietic cells: Effects of drug selection and of transcript splicing on expression of encoded P-glycoprotein . Hum Gene Ther 1999 ; 10 (13) : 2173-85 .
214. Zaboikin MM , Schuening FG . Poor expression of MDR1 transgene in HeLa cells by bicistronic Moloney murine leukemia virus-based vector . Hum Gene Ther 1998 ; 9 (15) : 2263-75 .
215. Cmejlova J , Hildinger M , Cmejla R , et al . Impact of splice-site mutations of the human MDR1 cDNA on its stability and expression following retroviral gene transfer . Gene Ther 2003 ; 10 (12) : 1061-5 .
216. Sorrentino BP , McDonagh KT , Woods D , Orlic D . Expression of retroviral vectors containing the human multidrug resistance 1 cDNA in hematopoietic cells of transplanted mice . Blood 1995 ; 86 (2) : 491-501 .
217. Hildinger M , Fehse B , Hegewisch-Becker S , et al . Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors . Hum Gene Ther 1998 ; 9 (1) : 33-42 .
218. Bunting KD , Galipeau J , Topham D , Benaim E , Sorrentino BP . Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice . Blood 1998 ; 92 (7) : 2269-79 .
219. Bunting KD , Zhou S , Lu T , Sorrentino BP . Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo . Blood 2000 ; 96 (3) : 902-9 .
220. Devereux S , Corney C , Macdonald C , et al . Feasibility of multidrug resistance (MDR-1) gene transfer in patients undergoing highdose therapy and peripheral blood stem cell transplantation for lymphoma . Gene Ther 1998 ; 5 (3) : 403-8 .
221. Sellers SE , Tisdale JF , Agricola BA , et al . The effect of multidrug-resistance 1 gene versus neo transduction on ex vivo and in vivo expansion of rhesus macaque hematopoietic repopulating cells . Blood 2001 ; 97 (6) : 1888-91 .
222. Gerson SL . Clinical releVance of MGMT in the treatment of cancer . J Clin Oncol 2002 ; 20 (9) : 2388-99 .
223. Wang JS , Sun DJ , Lin GW , Fei J . [A bicistronic retroviral vector containing MGMT and MDR1 drug resistance genes transfer into human umbilical cord blood CD34+ cells to improve combination chemotherapy tolerance] . Shi Yan Sheng Wu Xue Bao 2001 ; 34 (3) : 227-33 .
224. Maze R , Carney JP , Kelley MR , Glassner BJ , Williams DA , Samson L . Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis (2-chloroethyl)-1- nitrosourea, a chemotherapeutic alkylating agent . Proc Natl Acad Sci U S A 1996 ; 93 (1) : 206-10 .
225. Koc ON , Reese JS , Davis BM , Liu L , Majczenko KJ , Gerson SL . DeltaMGMT- transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis (2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts . Hum Gene Ther 1999 ; 10 (6) : 1021-30 .
226. Zielske SP , Reese JS , Lingas KT , Donze JR , Gerson SL . In vivo selection of MGMT (P140K) lentivirus-transduced human NOD/ SCID repopulating cells without pretransplant irradiation conditioning . J Clin Invest 2003 ; 112 (10) : 1561-70 .
227. Zielske SP , Lingas KT , Li Y , Gerson SL . Limited lentiviral transgene expression with increasing copy number in an MGMT selection model: lack of copy number selection by drug treatment . Mol Ther 2004 ; 9 (6) : 923-31 .
228. Davis BM , Roth JC , Liu L , Xu-Welliver M , Pegg AE , Gerson SL . Characterization of the P140K, PVP(138-140)MLK, and G156A O6-methylguanine-DNA methyltransferase mutants: Implications for drug resistance gene therapy . Hum Gene Ther 1999 ; 10 (17) : 2769-78 .
229. Davis BM , Koc ON , Gerson SL . Limiting numbers of G156A O(6)-methylguanine- DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection . Blood 2000 ; 95 (10) : 3078-84 .
230. Davis BM , Reese JS , Koc ON , Lee K , Schupp JE , Gerson SL . Selection for G156A O6-methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and protection from lethality in mice treated with O6-benzylguanine and 1,3-bis(2- chloroethyl)-1-nitrosourea . Cancer Res 1997 ; 57 (22) : 5093-9 .
231. Davis BM , Reese JS , Lingas K , Gerson SL . Drug selection of mutant methylguanine methyltransferase from different oncoretroviral backbones results in multilineage hematopoietic transgene expression in primary and secondary recipients . J Hematother Stem Cell Res 2003 ; 12 (4) : 375-87 .
232. Schambach A , Baum C . Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells . DNA Repair (Amst) 2007 ; 6 (8) : 1187-96 .
233. Williams DA , Maze R , Kurpad C , Pegg A , Erickson LC . Protection of hematopoietic cells against combined O6-benzylguanine and chloroethylnitrosourea treatment by mutant forms of O6-methylguanine DNA methyltransferase . Bone Marrow Transplant 2000 ; 25 (Suppl 2) : S105 - 9 .
234. Maze R , Kurpad C , Pegg AE , Erickson LC , Williams DA . Retroviral-mediated expression of the P140A, but not P140A/G156A, mutant form of O6-methylguanine DNA methyltransferase protects hematopoietic cells against O6-benzylguanine sensitization to chloroethylnitrosourea treatment . J Pharmacol Exp Ther 1999 ; 290 (3) : 1467-74 .
235. Lijinsky W , Kovatch RM , Singer SS . Carcinogenesis in F-344 rats induced by nitrosohydroxyalkyl- chloroethylureas . J Cancer Res Clin Oncol 1986 ; 112 (3) : 221-8 .
236. Greene MH , Boice JD , Jr. , Strike TA . Carmustine as a cause of acute nonlymphocytic leukemia . N Engl J Med 1985 ; 313 (9) : 579 .
237. Pizzorno G , Handschumacher RE . Effect of clinically modeled regimens on the growth response and development of resistance in human colon carcinoma cell lines . Biochem Pharmacol 1995 ; 49 (4) : 559-65 .
238. Sobrero AF , Aschele C , Bertino JR . Fluorouracil in colorectal cancer-a tale of two drugs: Implications for biochemical modulation . J Clin Oncol 1997 ; 15 (1) : 368-81 .
239. Ardalan B , Cooney DA , Jayaram HN , et al . Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracil . Cancer Res 1980 ; 40 (5) : 1431-7 .
240. Randall TD , Weissman IL . Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment . Blood 1997 ; 89 (10) : 3596-606 .
241. Klug CA , Cheshier S , Weissman IL . Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny . Blood 2000 ; 96 (3) : 894-901 .
242. Goebel WS , Yoder MC , Pech NK , Dinauer MC . Donor chimerism and stem cell function in a murine congenic transplantation model after low-dose radiation conditioning: Effects of a retroviral-mediated gene transfer protocol and implications for gene therapy . Exp Hematol 2002 ; 30 (11) : 1324-32 .
243. Shultz LD , Lyons BL , Burzenski LM , et al . Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells . J Immunol 2005 ; 174 (10) : 6477-89 .
244. Pollok KE , Van Der Loo JC , Cooper RJ , et al . Differential transduction efficiency of SCIDrepopulating cells derived from umbilical cord blood and granulocyte colony-stimulating factor-mobilized peripheral blood . Hum Gene Ther 2001 ; 12 (17) : 2095-108 .
245. Abe T , Ito M , Okamoto Y , et al . Transduction of retrovirus-mediated NeoR gene into CD34+ cells purified from granulocyte colony-stimulating factor (G-CSF)-mobilized infant and cord blood . Exp Hematol 1997 ; 25 (9) : 966-71 .
246. Lu L , Xiao M , Clapp DW , Li ZH , Broxmeyer HE . High efficiency retroviral mediated gene transduction into single isolated immature and replatable CD34(3+) hematopoietic stem/progenitor cells from human umbilical cord blood . J Exp Med 1993 ; 178 (6) : 2089-96 .
247. Veena P , Traycoff CM , Williams DA , et al .Delayed targeting of cytokine-nonresponsive human bone marrow CD34(+) cells with retrovirus-mediated gene transfer enhances transduction efficiency and longterm expression of transduced genes . Blood 1998 ; 91 (10) : 3693-701 .
248. Koizumi K , Nishio M , Endo T , et al . Large scale purification of human blood CD34+ cells from cryopreserved peripheral blood stem cells, using a nylon-fiber syringe system and immunomagnetic microspheres . Bone Marrow Transplant 2000 ; 26 (7) : 787-93 .
249. McNiece IK , Stoney GB , Kern BP , Briddell RA . CD34+ cell selection from frozen cord blood products using the Isolex 300i and CliniMACS CD34 selection devices . J Hematother 1998 ; 7 (5) : 457-61 .
250. Rubinstein P , Dobrila L , Rosenfield RE , et al . Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution . Proc Natl Acad Sci U S A 1995 ; 92 (22) : 10119-22 .
251. Martinson JA , Loudovaris M , Smith SL , et al . Ex vivo expansion of frozen/thawed CD34+ cells isolated from frozen human apheresis products . J Hematother 1997 ; 6 (1) : 69-75 .
252. Christianson SW , Greiner DL , Hesselton RA , et al . Enhanced human CD4+ T cell engraftment in beta2-microglobulin- deficient NOD-scid mice . J Immunol 1997 ; 158 (8) : 3578-86 .
253. Kollet O , Peled A , Byk T , et al . beta2 microglobulin- deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function . Blood 2000 ; 95 (10) : 3102-5 .
254. Hiramatsu H , Nishikomori R , Heike T , et al . Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/gammacnull mice model . Blood 2003 ; 102 (3) : 873-80 .
255. Piacibello W , Gammaitoni L , Bruno S , et al . Negative influence of IL3 on the expansion of human cord blood in vivo long-term repopulating stem cells . J Hematother Stem Cell Res 2000 ; 9 (6) : 945-56 .
256. McGuckin CP , Forraz N , Pettengell R , Thompson A . Thrombopoietin, flt3-ligand and c-kit-ligand modulate HOX gene expression in expanding cord blood CD133 cells . Cell Prolif 2004 ; 37 (4) : 295-306 .
257. Kurre P , Morris J , Miller AD , Kiem HP . Envelope fusion protein binding studies in an inducible model of retrovirus receptor expression and in CD34(+) cells emphasize limited transduction at low receptor levels . Gene Ther 2001 ; 8 (8) : 593-9 .
258. Yu SS , Kim JM , Kim S . The 17 nucleotides downstream from the env gene stop codon are important for murine leukemia virus packaging . J Virol 2000 ; 74 (18) : 8775-80 .
259. Ory DS , Neugeboren BA , Mulligan RC .stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes . Proc Natl Acad Sci U S A 1996 ; 93 (21) : 11400-6 .
260. Schnell S , Young JW , Houghton AN , Sadelain M . Retrovirally transduced mouse dendritic cells require CD4+ T cell help to elicit antitumor immunity: Implications for the clinical use of dendritic cells . J Immunol 2000 ; 164 (3) : 1243-50 .
261. Petzer AL , Hogge DE , Landsdorp PM , Reid DS , Eaves CJ . Self-renewal of primitive human hematopoietic cells (long-termculture- initiating cells) in vitro and their expansion in defined medium . Proc Natl Acad Sci U S A 1996 ; 93 (4) : 1470-4 .
262. Seppen J , Kimmel RJ , Osborne WR . Serum-free production, concentration and purification of recombinant retroviruses . Biotechniques 1997 ; 23 (5) : 788-90 .
263. Reeves L , Smucker P , Cornetta K . Packaging cell line characteristics and optimizing retroviral vector titer: The National Gene Vector Laboratory experience . Hum Gene Ther 2000 ; 11 (15) : 2093-103 .
264. Reeves L , Cornetta K . Clinical retroviral vector production: Step filtration using clinically approved filters improves titers . Gene Ther 2000 ; 7 (23) : 1993 - 8 .
265. Schambach A , Galla M , Modlich U , et al . Lentiviral vectors pseudotyped with murine ecotropic envelope: Increased biosafety and convenience in preclinical research . Exp Hematol 2006 ; 34 (5) : 588-92 .
266. Schilz AJ , Kuhlcke K , Fauser AA , Eckert HG . Optimization of retroviral vector generation for clinical application . J Gene Med 2001 ; 3 (5) : 427-36 .
267. Kotani H , Newton PB , 3 rd , Zhang S , et al . Improved methods of retroviral vector transduction and production for gene therapy . Hum Gene Ther 1994 ; 5 (1) : 19-28 .
268. Carmo M , Faria TQ , Falk H , et al . Relationship between retroviral vector membrane and vector stability . J Gen Virol 2006 ; 87 (Pt 5) : 1349-56 .
269. Wikstrom K , Blomberg P , Islam KB . Clinical grade vector production: Analysis of yield, stability, and storage of gmp-produced retroviral vectors for gene therapy . Biotechnol Prog 2004 ; 20 (4) : 1198-203 .
270. Carmo M , Peixoto C , Coroadinha AS , Alves PM , Cruz PE , Carrondo MJ . Quantitation of MLV-based retroviral vectors using real-time RT-PCR . J Virol Methods 2004 ; 119 (2) : 115-9 .
271. Sanburn N , Cornetta K . Rapid titer determination using quantitative real-time PCR . Gene Ther 1999 ; 6 (7) : 1340-5 .
272. Scott-Taylor TH , Gallardo HF , Gansbacher B , Sadelain M . Adenovirus facilitated infection of human cells with ecotropic retrovirus . Gene Ther 1998 ; 5 (5) : 621-9 .
273. Higashikawa F , Chang L . Kinetic analyses of stability of simple and complex retroviral vectors . Virology 2001 ; 280 (1) : 124-31 .
274. Andreadis ST , Brott D , Fuller AO , Palsson BO . Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours . J Virol 1997 ; 71 (10) : 7541-8 .
275. McTaggart S , Al-Rubeai M . Effects of culture parameters on the production of retroviral vectors by a human packaging cell line . Biotechnol Prog 2000 ; 16 (5) : 859-65 .
276. Quintas-Cardama , A. , Yeh , R. K. , Hollyman , D. , Stefanski , J. , Taylor , C. , Nikhamin , Y. , Imperato , G. , Sadelain , M. , Riviere , I. , and Brentjens , R. J. (2007) Hum Gene Ther 18 , 1253-60 .